524494:BOM
IPCA Laboratories Ltd
₹1,649.90
arrow_upward
+1.85%(+30.00) 1D
Jun 5, 3:30:00 PM GMT+5:30 · INR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 524494...
Open
₹1,613.00
High
₹1,650.00
Low
₹1,610.70
Mkt. cap
417.85B
Avg. vol.
38.02K
Volume
17.69K
Dividend
0.36%
Quarterly dividend
₹1.50
Ex-dividend date
Aug 7, 2026
P/E ratio
36.68
52-wk high
₹1,679.45
52-wk low
₹1,252.95
EPS
₹44.98
Shares outstanding
126.35M
No. of employees
17K
Open
₹1,613.00
High
₹1,650.00
Low
₹1,610.70
Mkt. cap
417.85B
Avg. vol.
38.02K
Volume
17.69K
Dividend
0.36%
Quarterly dividend
₹1.50
Ex-dividend date
Aug 7, 2026
P/E ratio
36.68
52-wk high
₹1,679.45
52-wk low
₹1,252.95
EPS
₹44.98
Shares outstanding
126.35M
No. of employees
17K
News stories
From sources across the web
Investment Guru India
·
23 hours ago
Buy Ipca Laboratories Ltd for the Target Rs.1,730 by Motilal Oswal Financial Services Ltd
The Economic Times
·
2 days ago
Eris Lifesciences - Ipca Laboratories among 5 stocks showing bullish RSI upswing
The Financial Express
·
3 days ago
IPCA Laboratories: Emkay Global sees 21% upside; projects 12–13% FY27 sales growth
Profile
Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients. Ipca sells these APIs and their intermediates globally. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules. Wikipedia
About IPCA Laboratories Ltd
AI content may include mistakes. Learn more